호냉성 해양세균 Shewanella sp. L93로부터 Eicosapentaenoic Acid 생산 및 정제를 위한 최적화 조건 = Optimal Condition for Eicosapentaenoic Acid Production and Purification from Psychrophillic Marine Baterium Shewanella sp

국문 초록 (Abstract)

Eicosapentaenoic acid 생산 세균을 얻기 위해 1999~2000년 하계연구 기간 중에 남극 생물 및 침적토를 사용하여 600주의 균주를 분리하였고 TLC와 GC를 사용하여 오메가-3고도불포화 지방산 EPA를 생산하는 미생물 7 주를 성공적으로 분리하였으며, 이중 EPA 생산이 가장 높은 L93 균주를 선발하였다. 16S rDNA의 염기서열 분석을 통하여 Shewanella 속으로 조사되었으며, 이에 분리된 균주를 Shewanella sp. L93라 명명하였다. EPA를 생산 최적 배양온도 4℃ 이며, 초기 pH 7에서 최적 EPA 함량을 보였다. 아울러 염 농도는 50 %(w/v)에서 생산이 최대였다. EPA 최적생산 조건을 이용하여 리터당 320 mg을 생산할 수 있는 생산 시스템을 확립하였다. Urea 침전법과 HPLC을 이용하여 수율 72% 이상의 97% 순도를 가진 EPA를 정제할 수 있는 분리 정제 시스템 또한 본 연구를 통하여 확립하였다.

다국어 초록 (Multilingual Abstract)

To obtain eicosapentaenoic acid (EPA)-producing bacteria, some 600 strains of bacteria were isolated from Antarctic sediment and marine organisms during the summer expedition of 1999-2000 and 7 EPA-producing bacteria were obtained through screening with TLC and GC. A strain designated as L93 showed the highest EPA production, which was gram-negative, rod-shaped bacterium. L93 strain was identified as Shewanella sp., from the sequence analysis of 16S rDNA. Optimal conditions temperature and pH for the growth and EPA production were about 4℃ and pH 7. In addition, its production was optimized by 50%(w/v) sea salt. We establish the optimal production system to produce about 320 mg per liter by using this optimal EPA production conditions. EPA-methyl ester was purified from cultured L93 strain to a purity of higher than 97% and typical purification yield is greater than 72% of the input amount via urea complexation and HPLC.

참고문헌 (Reference)

1 Kelly,J.F, "The metabolic role of n - 3 polyunsaturatedfatty acids: relationship to human disease" 98 : 581-585, 1991

2 Pettinella, C., "Targeted quantitative analysis of fatty acids in atheroscleroticplaques by high sensitivity liquid chromatography/tandemmass spectrometry" 850 : 168-176, 2007

3 Bowman, J. P., "Shewanella gelidimarina sp. nov. and Shewanellafrigidimarina sp. nov., novel Antarctic species with theability to produce eicosapentaenoic acid (20:5 omega 3) andgrow anaerobically by dissimilatory Fe(III) reduction" 47 : 1040-1047, 1997

4 모상준, "Screening and characterization of eicosapentaenoic acid-producing marine bacteria" SPRINGER 21 : 215-218, 1999

5 Yazawa, K., "Production ofeicosapentaenoic acid by marine bacteria" 103 : 5-7, 1988

6 Bang, H. O, "Plasma lipids andlipoproteins in Gleenlandic west coast Eakimos" 192 : 85-94, 1972

7 Lane,D.J, "Nucleic acid techniques in bacterial systematic" John Wiley and Sons 115-175, 1991

8 Dyerberg, J, "Lipid metabolism,atherogenesis, and haemostasis in Eskimos: the role of theprostaglandin-3 family" 8 : 227-233, 1979

9 Christie,W.W, "Lipid Analysis" Pergamon Press 1982

10 이수진, "Isolation and Characterization of the Eicosapentaenoic Acid Biosynthesis Gene Cluster from Shewanella sp. BR-2" 한국미생물·생명공학회 19 (19): 881-887, 2009

11 이원회, "Identification of Psychrophile Shewanella sp. KMG427 as an Eicosapentaenoic Acid Producer" 한국미생물·생명공학회 18 (18): 1869-1873, 2008

12 Salunkhe, D., "Halomonas sp. nov., an EPA-producing mesophilicmarine isolate from the Indian Ocean" 60 : 73-78, 2011

13 Lopoz Alonso, D., "Fatty acidvariation among different isolates of a single strain ofIsochrysis galbana" 31 : 3901-3904, 1992

14 Dyeberg, J., "Eicosapentaenoic acid and prevention ofthrombosis and atherosclerosis" 2 : 117-119, 1978

15 Taketama, H., "DHA enrichment of rotifers: A simpletwo-step culture using the unicellula algae chlorella regularisand Isochrysis galbana" 3 : 244-247, 1996

16 Connor, S. L, "Are fish oils beneficalin the prevention and treatment of coronary arterydisease" 66 : 1020-1031, 1997